ATLANTA, GA – – (Globe Newswire – April 7, 2025) – – A shareholder class action lawsuit has been filed against Viatris Inc. (“Viatris” or “the Company”) (NASDAQ: VTRS). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts regarding the impact of the FDA’s Warning Letter on Viatris’ financials.

If you bought shares of Viatris between August 8, 2024 and February 26, 2025, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/viatris/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is June 3, 2025.